↓ Skip to main content

CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+disease

Overview of attention for article published in Breast Cancer Research, December 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent
10 patents

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+disease
Published in
Breast Cancer Research, December 2009
DOI 10.1186/bcr2454
Pubmed ID
Authors

Robert L Sutherland, Elizabeth A Musgrove

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 3%
France 1 2%
Czechia 1 2%
Iran, Islamic Republic of 1 2%
Egypt 1 2%
Mexico 1 2%
United States 1 2%
Unknown 57 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 28%
Student > Ph. D. Student 12 18%
Student > Master 7 11%
Student > Doctoral Student 5 8%
Other 5 8%
Other 12 18%
Unknown 6 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 37%
Medicine and Dentistry 11 17%
Biochemistry, Genetics and Molecular Biology 8 12%
Chemistry 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 6 9%
Unknown 8 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#2,863,727
of 25,373,627 outputs
Outputs from Breast Cancer Research
#296
of 2,052 outputs
Outputs of similar age
#13,581
of 176,302 outputs
Outputs of similar age from Breast Cancer Research
#3
of 17 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,302 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.